Table 4 Number of cardiovascular events (1000 person-years) in subjects in study 1 (A) and study 2 (B)
N | The number of cardiovascular events | 1000 person-years | |
|---|---|---|---|
(A) | |||
SU | 629 | 80 | 108.9 |
BG | 1305 | 84 | 51.0 |
α-GI | 592 | 63 | 91.3 |
TZD | 351 | 35 | 82.3 |
Glinide | 223 | 21 | 71.2 |
DPP-4 inhibitor | 995 | 87 | 105.2 |
(B) | |||
SU | 228 | 58 | 224.0 |
BG | 325 | 47 | 106.2 |
α-GI | 203 | 40 | 159.4 |
TZD | 140 | 26 | 154.7 |
Glinide | 70 | 14 | 162.1 |
DPP-4 inhibitor | 307 | 56 | 222.7 |